Expertise in
26
conditions

Toshiaki A. Takahashi

Shizuoka, JP 
Expertise in
26
conditions
Shizuoka, JP 

Overview

Toshiaki Takahashi practices practicing medicine in Shizuoka, Japan.

Mr. Takahashi is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Lung Agenesis, Diaphragmatic Hernia, Congenital Diaphragmatic Hernia, Osteotomy, and Endoscopy.

He is actively involved in clinical research, co-authoring 543 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Shizuoka, Japan
Other Locations
Shinjuku, Japan
Okayama, 7008530, Japan
Sapporo, Japan
Sendai, Japan
Shimonagakubo, 4118777, Japan
Hamamatsu, Japan
Tokyo, Japan
Kashiwa, 2778583, Japan
Hongo, Japan
Nakakido, 9500862, Japan
Matsuyama, 7908577, Japan
Kiryu, Japan
Toranomon, Japan
Sennan, 5900494, Japan
Morioka, 0208550, Japan
Ichihara, 2900045, Japan
Kamogawa, Japan
Osaka, Japan
Toyohashi, 4418580, Japan
Tottori, Japan
Yamagata, 9902212, Japan
Fukuoka, Japan
Niigata, Japan
Toon, Japan
Chiyoda, 1018308, Japan
Kyoto, 6068502, Japan
Yokote, Japan
Sanda, Japan
Akita, Japan
Hiraka, Japan
Japan
Nankoku, 7838505, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Multicenter, Double Blind, Randomized, Controlled Study of M7824 With Concurrent Chemoradiation Followed by M7824 Versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants With Unresectable Stage III Non-small Cell Lung Cancer
A Multicenter, Double Blind, Randomized, Controlled Study of M7824 With Concurrent Chemoradiation Followed by M7824 Versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants With Unresectable Stage III Non-small Cell Lung Cancer
Enrollment Status: Terminated
Publish Date: January 16, 2024
Intervention Type: Drug, Radiation
Study Drugs: M7824, Durvalumab, Etoposide, Pemetrexed, Carboplatin, Paclitaxel, Cisplatin
Study Phase: Phase 2

543 Total Publications

Benchmarking Zero-Shot Generative Pre-Trained Transformer-Based Multimodal Large Language Models for Pressure Injury Staging.
Benchmarking Zero-Shot Generative Pre-Trained Transformer-Based Multimodal Large Language Models for Pressure Injury Staging.
Journal: Advances in wound care
Published: July 03, 2026

Frequently Asked Questions about Toshiaki A. Takahashi

Is Toshiaki A. Takahashi a top-rated expert for Lung Agenesis?

MediFind is an objective health platform that identifies experts based on real-world data. Toshiaki A. Takahashi is classified as an Elite expert for Lung Agenesis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Toshiaki A. Takahashi participate in research or clinical trials?

Yes. Toshiaki A. Takahashi has published 543 articles and abstracts on conditions like Lung Agenesis. You can view a list of Toshiaki A. Takahashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Takahashi's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 15 Advanced Conditions
View All 75 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile